// App-Quantinova.ai

476.0 : A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).

Researchers

Presenter

  • Winson Y. Cheung

Principal Investigators

  • Hanbo Zhang

  • Patricia A. Tang

  • Jennifer L. Spratlin

  • Richard M. Lee-Ying

  • Rachel Anne Goodwin

  • Brandon Matthew Meyers

  • Dawn Elizabeth Armstrong

  • Ravi Ramjeesingh

  • Michael M. Vickers

  • Christina Kim

Medical Centers

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • National Cancer Institute of Canada Clinical Trials Group, The Ottawa Hospital, Ottawa, ON, Canada

  • Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada

  • Dr. H. Bliss Murphy Cancer Centre, St John's, NF, Canada

  • Nova Scotia Cancer Centre, Dalhousie University, Nova Scotia, NS, Canada

  • University of Ottawa, Ottawa, ON, Canada

  • Cancer Care Manitoba, Winnipeg, MB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Adenomatous Polyposis Coli

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved